ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,042, issued on June 17.

"Compounds suitable for the treatment and prophylaxis of muscle wasting and other conditions" was invented by Volker Adams (Leipzig, Germany) and Siegfried Labeit (Neckargemund, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a compound of the general formula I and the pharmaceutically acceptable salts thereof; where the variables are as defined in the claims and the description. The invention also relates to the compounds of formula I for use in the treatment or prophylaxis of muscle wasting conditions, of skeletal or cardial muscle atrophy, of conditions, in particular of myopathies, ...